🇺🇸 Indom in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Azotaemia — 1 report (10%)
  2. Blood Bilirubin Decreased — 1 report (10%)
  3. Blood Creatinine Increased — 1 report (10%)
  4. Blood Lactate Dehydrogenase Decreased — 1 report (10%)
  5. Blood Phosphorus Increased — 1 report (10%)
  6. Blood Uric Acid Increased — 1 report (10%)
  7. Central Serous Chorioretinopathy — 1 report (10%)
  8. Glomerular Filtration Rate Decreased — 1 report (10%)
  9. Haemoglobin Decreased — 1 report (10%)
  10. Lipase Increased — 1 report (10%)

Source database →

Indom in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is Indom approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Indom in United States?

University of Trieste is the originator. The local marketing authorisation holder may differ — check the official source linked above.